Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (141-150 of 354) with videos related to

Pageof 36
Sort By:
Nature|June 6, 2020
BCR selection and affinity maturation in Peyer's patch germinal centresHuan Chen, Yuxiang Zhang, Adam Yongxin Ye, et al.
Leukemia & Lymphoma|March 5, 2003
Quantitative monitoring of BCR/ABL transcript during STI-571 therapyCatherine J Wu, Donna Neuberg, Antoinette Chillemi, et al.
Blood|July 15, 2010
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphomaMichael R Green, Stefano Monti, Scott J Rodig, et al.
British Journal of Haematology|August 30, 2008
Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disordersJennifer R Brown, Donna Neuberg, Kimberly Phillips, et al.
Blood|August 5, 2024
JAK2-mutant clonal hematopoiesis is associated with venous thromboembolismRebecca L Zon, Aswin Sekar, Katharine Clapham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2002
Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphomaIain J Webb, nathan W Friedberg, John G Gribben, et al.
American Journal of Hematology|April 10, 2021
Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following inductionJ Erika Haydu, Yael Flamand, Rahul S Vedula, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancerRebecca Suk Heist, Wei Zhou, Zhaoxi Wang, et al.
Transfusion|February 14, 2004
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapyAbba C Zubair, David Zahrieh, Heather Daley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 30, 2011
Hutchinson-Gilford progeria is a skeletal dysplasiaCatherine M Gordon, Leslie B Gordon, Brian D Snyder, et al.
Pageof 36

Showing results (141-150 of 354) with videos related to

Sort By:
Pageof 36
Nature|June 6, 2020
BCR selection and affinity maturation in Peyer's patch germinal centresHuan Chen, Yuxiang Zhang, Adam Yongxin Ye, et al.
Leukemia & Lymphoma|March 5, 2003
Quantitative monitoring of BCR/ABL transcript during STI-571 therapyCatherine J Wu, Donna Neuberg, Antoinette Chillemi, et al.
Blood|July 15, 2010
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphomaMichael R Green, Stefano Monti, Scott J Rodig, et al.
British Journal of Haematology|August 30, 2008
Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disordersJennifer R Brown, Donna Neuberg, Kimberly Phillips, et al.
Blood|August 5, 2024
JAK2-mutant clonal hematopoiesis is associated with venous thromboembolismRebecca L Zon, Aswin Sekar, Katharine Clapham, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2002
Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphomaIain J Webb, nathan W Friedberg, John G Gribben, et al.
American Journal of Hematology|April 10, 2021
Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following inductionJ Erika Haydu, Yael Flamand, Rahul S Vedula, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancerRebecca Suk Heist, Wei Zhou, Zhaoxi Wang, et al.
Transfusion|February 14, 2004
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapyAbba C Zubair, David Zahrieh, Heather Daley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 30, 2011
Hutchinson-Gilford progeria is a skeletal dysplasiaCatherine M Gordon, Leslie B Gordon, Brian D Snyder, et al.
Pageof 36